At iama therapeutics, we strive to develop innovative medicines for brain disorders with unmet medical needs.
We push the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of individuals suffering from brain disorders.
We seek to couple emerging advances in drug discovery and neurobiology to build a leading, next-generation neuroscience pipeline.
We have developed a platform to identify and advance diverse classes of small molecules to selectively inhibit the sodium-potassium chloride cotransporter (NKCC1) and other therapeutic targets relevant to treating central nervous system disorders.
Working at Iama therapeutics
Our core values root in excellence, innovation, integrity, equality, respect for diversity, and sustainability of our future generations.